ATC code L
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
Pharmaceutical drug classification
ATC code L:Antineoplastic and immunomodulating agents |
---|
Other ATC codes |
ATC code LAntineoplastic and immunomodulating agentsis a section of theAnatomical Therapeutic Chemical Classification System,a system of Alpha numeric codes developed by theWorld Health Organization(WHO) for the classification ofdrugsand other medical products.[1][2][3][4]
Codes forveterinaryuse (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example,QL.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
[edit]- ^"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis".National Institutes of Health.Retrieved1 February2020.
- ^World Health Organization."Anatomical Therapeutic Chemical (ATC) Classification".World Health Organization.Retrieved3 January2022.
- ^"Structure and principles".WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018.Retrieved3 January2022.
- ^"ATC/DDD Index 2022: code L".WHO Collaborating Centre for Drug Statistics Methodology.
- ^"ATCvet Index 2022: code QL".WHO Collaborating Centre for Drug Statistics Methodology.
CImonoclonal antibodies( "-mab" ) |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Tyrosine kinase inhibitors( "-nib" ) |
| ||||||||
Other |
|
Endogenous |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exogenous |
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
| ||||||||||||||
Unsorted |
|